Heart MRI for COVID-19 Survivors
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
Recruiting
Observational Study
COVID-19 Pneumonia
COVID-19
COVID-19 Respiratory Infection
COVID-19 Acute Respiratory Distress Syndrome
COVID-19 Lower Respiratory Infection
COVID-19 Acute Bronchitis
Coronavirus Disease 2019
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 510 (estimated)
- Sponsor
- Weill Medical College of Cornell University · Other
Who this trial is looking for
This trial is looking for people who have survived COVID-19 and had symptoms like difficulty breathing or cough. Participants will undergo heart imaging tests to help understand ongoing heart and lung issues after COVID-19.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been hospitalized with COVID-19.
- I have tested positive for COVID-19.
- I have experienced symptoms like cough or difficulty breathing.
You may not be able to join if
- I cannot provide informed consent.
- I have severe kidney problems.
- I have a medical device like a pacemaker that is not compatible with MRI.
- I am pregnant or suspect I might be.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The purpose of this study is to test if visualizing the heart with cardiac MRI/echo will be important in the understanding cardiac function and prediction of cardiopulmonary symptoms, physical effort tolerance, and outcomes in COVID-19 survivors. If successful, the research will allow us to identify the causes of lasting cardiopulmonary symptoms and begin developing cardiac and lung directed thera…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Emergency room presentation and/or hospitalization with COVID-19 infection defined in accordance with established criteria as follows: SAR-CoV2 RT-PCR+ (severe acute respiratory syndrome coronavirus 2 reverse transcription polymerase chain reaction) and at least one of the fol…
Contacts